Medical Condition

acute coronary syndrome

Total Trials

20

Recruiting Now

20

Trial Phases

Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for acute coronary syndrome sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — acute coronary syndrome Clinical Trials

How many clinical trials are currently recruiting for acute coronary syndrome?

ClinicalMetric currently tracks 20 actively recruiting clinical trials for acute coronary syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 20. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for acute coronary syndrome?

acute coronary syndrome research spans Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a acute coronary syndrome clinical trial?

Eligibility criteria for acute coronary syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 3

Phase 4

Top Sponsors

Angel Medical Systems 1 trial

Novartis Pharmaceuticals 1 trial

Assistance Publique - Hôpitaux de Paris 1 trial

pablo Juan-Salvadores 1 trial

National University Hospital, Singapore 1 trial

acute coronary syndrome

Frequently Asked Questions — acute coronary syndrome Clinical Trials

Recruiting Clinical Trials

AngelMed Guardian® System PMA Post Approval Study

Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes

Impact of COVID19 Outbreak in Cardiac Acute Care

Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease

Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis

The Harefield Acute Myocardial Infarction Cohort

European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation

Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)

Thrombus Aspiration and Pathology and OCT Study

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome

Prospective Multicenter Registry of Gender, Diversity and Inclusion (GEDI) of Women With Acute Coronary Syndrome

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

Guideline Oriented Approach To Lipid Lowering In Asia-Pacific

Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI

Cellular Immunity, Neuroendocrine, and Inflammatory Factors for Clinical Prognosis in Acute Coronary Syndrome

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

A Prospective Research Investigation of Ischemia Using MCG

South East (Zuid Oost) Netherlands Heart Registry